Optimization of a microfluidic device for single bacterial cell genomics
Optimization of a microfluidic device for single bacterial cell genomics
批准号:
7893813
负责人:
DAVID A. RELMAN
金额:
$58.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2013-07-31
关键词:
AutomationBiologyCell CountCell SeparationCellsCommunitiesDNADNA Sequence AnalysisDataDevelopmentDevicesDiagnosisDiseaseEnvironmental PollutionFluorescent in Situ HybridizationGene ExpressionGenomeGenomicsGoalsHealthHumanHuman MicrobiomeHuman bodyIndigenousIndividualLasersLeadLifeMeasuresMicrofluidic MicrochipsMicrofluidicsNoiseOpticsOral cavityProtocols documentationPublic HealthRNAReagentResearchReverse TranscriptionSamplingScienceSignal TransductionSpeedSurveysTechniquesTechnologyTestingTranscriptUnited States National Institutes of HealthWorkcell typedesigndigitalfluorescence imaginggenome sequencingimprovedmembermicrobialmicrobial communitymicroorganismnanolitrenew technologynovelpublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The quest to characterize the human microbiome is a daunting goal, but one that promises to enhance significantly our understanding of health and our management of a wide variety of disease states. In this quest, two features of the human microbiota in particular, pose major challenges: the large proportion and number of as-yet uncultivated species, and the extreme unevenness of the microbial communities, with a resulting large number of potentially important community members that fail to be "seen" in routine surveys. The ability to identify, isolate, and sequence the genome of single bacterial cells would allow us to characterize and understand both rare and uncultivated microbial species, and materially advance our understanding of the human microbiome. In recent work, a microfluidic device has been designed and fabricated, with features that mimic an integrated electrical circuit; this device isolates individual bacterial cells, and allows their genome to be amplified in nanoliter volumes. In this Application, a plan is proposed for optimization and augmentation of this microfluidics device, so that environmental contamination is reduced, rare cell types are more easily captured, larger numbers of cells are screened more quickly, and gene expression is more easily measured from single cells. The long-term objectives of this work are to enhance our understanding of the human microbial communities, and in particular, of novel or poorly-characterized, uncultivated microbial community members. This proposal responds to critical unmet needs posed by the NIH Human Microbiome Project. The following are the Specific Aims of this proposal: Aim 1. To reduce the contribution of environmental DNA to single cell genomic sequence data, and increase the "signal-to-noise" ratio of the sequence data obtained with our cell- sorting, genome amplification microfluidics device. The experimental approach involves the integration of optical (laser) tweezers into the device. Aim 2. To improve the ability to detect and capture rare microbial community members with the microfluidics device. The experimental approach involves the integration of fluorescence in situ hybridization techniques, specific probes, and fluorescence imaging with the microfluidics device. Aim 3. To increase the speed of single cell selection and isolation with the microfluidics device. The experimental approach involves more highly parallel microdevice designs, optimization of laser power and laser optical path, and further automation of cell manipulations. Aim 4. To enhance the capability for gene expression analysis in single bacterial cells. The experimental approach involves the development of on-chip protocols for RNA isolation, reverse transcription, and use of digital PCR to quantify transcript abundance from single cells. PUBLIC HEALTH RELEVANCE: This research is relevant to public health because it will lead to a better understanding of the microorganisms that live on and in the human body. Because the human indigenous microbial communities help to maintain health and when disturbed, contribute to disease, this research may lead to new tests for diagnosing or predicting disease associated with microbial community disturbance, and new strategies for maintaining or restoring health.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0016626
发表时间:
2011-02-22
期刊:
PloS one
影响因子:
3.7
作者:
[Blainey PC, Mosier AC, Potanina A, Francis CA, Quake SR]
通讯作者:
Quake SR
DOI:
10.1093/nar/gkq1074
发表时间:
2011-03
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Blainey PC, Quake SR]
通讯作者:
Quake SR
DOI:
10.1111/1574-6976.12015
发表时间:
2013-05
期刊:
FEMS microbiology reviews
影响因子:
11.3
作者:
[Blainey PC]
通讯作者:
Blainey PC
Household transmission of the human gut microbiota after antibiotic exposure
-
批准号:10593834
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2022
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10624323
-
项目类别:
-
资助金额:$71.51万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10176389
-
项目类别:
-
资助金额:$72.61万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Microbial dispersal, skin-to-skin contact, and assembly of the neonatal gut microbiome
-
批准号:10178070
-
项目类别:
-
资助金额:$11.83万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an Antibiotic
-
批准号:10404963
-
项目类别:
-
资助金额:$72.05万
-
财政年份:2020
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8889677
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:8606066
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Environmental Arsenic Exposure, Microbiome, and Human Health
-
批准号:9113017
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Integration of Microbe and Host Data Diagnosis of Febrile Illness
-
批准号:9241962
-
项目类别:
-
资助金额:$108.16万
-
财政年份:2014
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8579781
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:9052450
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8878218
-
项目类别:
-
资助金额:$57.57万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Hyposalivation and the Human Oral Microbiome
-
批准号:8672626
-
项目类别:
-
资助金额:$63.35万
-
财政年份:2013
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8412747
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Antibiotics and Human Microbial Community Dynamics
-
批准号:8975217
-
项目类别:
-
资助金额:$27.65万
-
财政年份:2012
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:8260250
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2011
-
负责人:DAVID A. RELMAN
-
依托单位:
Transcriptional profiles of the host response to dengue fever
-
批准号:7675064
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7571520
-
项目类别:
-
资助金额:$55.85万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7940507
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
Optimization of a microfluidic device for single bacterial cell genomics
-
批准号:7691405
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2008
-
负责人:DAVID A. RELMAN
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: